ethinyl estradiol has been researched along with nuvaring in 46 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 17 (36.96) | 29.6817 |
| 2010's | 27 (58.70) | 24.3611 |
| 2020's | 2 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Aubeny, E; Bastianelli, C; Birkhäuser, MH; Bjertnaes, A; Gruber, CJ; Knudsen, T; Lete, I; Lindh, I; Milsom, I; Rokstad, K | 1 |
| Ahrendt, HJ; Bastianelli, C; Bitzer, J; Gemzell-Danielsson, K; Gómez, MA; Karskov, B; Milsom, I; Nisand, I; Oeyen, L; Page, G; Urdl, W | 1 |
| Reeves, MF | 1 |
| Atlas, M; Gordon, L; Januchowski, R; Thakur, N | 1 |
| Hund, M; Merki-Feld, GS | 1 |
| Bischof, P; de Ziegler, D; Fraisse, T; Ibecheole, V; Pillet, C; Streuli, I | 1 |
| Camacho, DP; Consolaro, ME; Donatti, L; Gasparetto, A; Patussi, EV; Svidzinski, TI | 1 |
| Andreeva, EN; Chebotnikova, TV; Grigoryan, OR; Grodnitskaya, EE; Melnichenko, GA | 1 |
| Batashki, I; Dinov, I; Ivanov, S | 1 |
| Escudero Fernández, JM; Martínez de Osaba Madariaga, MJ; Rabinovich, IH | 1 |
| Bruni, V; Luisi, S; Petraglia, F; Pontello, V | 1 |
| Coffee, A; Kuehl, AL; Kuehl, TJ; Smith, V; Sulak, PJ; Witt, I | 1 |
| Shimoni, N; Westhoff, C | 1 |
| Barnhart, KT; Charlesworth, S; Creinin, MD; Gracia, CR; Lin, H; Sammel, MD | 1 |
| Debski, R; Kotarski, J; Paszkowski, T; Pawelczyk, L; Skrzypulec, V; Tomaszewski, J | 1 |
| Bhaduri, M; Carr, LK; Dunn, S; Glanc, P | 1 |
| Taéron, C | 1 |
| Gilliam, ML; Godfrey, E; Kozloski, M; Mistretta, S; Neustadt, A; Tilmon, S | 1 |
| Andreeva, EN; Dedov, II; Grigoryan, OR; Grodnitskaya, EE; Klinyshkova, EV; Melnichenko, GA | 1 |
| Edwardson, J; Jamshidi, R | 1 |
| Weisberg, E | 1 |
| Fait, T | 1 |
| Bitzer, J | 1 |
| El-Sherbiny, WS; Mohamed, AM; Mostafa, WA | 1 |
| Alhajri, M; Greenblatt, E; Liu, KE | 1 |
| Abu Hashim, H; Alsherbini, W; Bazeed, M | 1 |
| Liang, BA; Lovett, KM; Mackey, TK | 1 |
| Mishell, DR; Roumen, FJ | 1 |
| Corbett, ST; Ehdaie, B; Mason, MD; Peters, CA | 1 |
| Clark, MR; Externbrink, A; Friend, DR; Klein, S | 1 |
| Dinger, J; Heinemann, K; Möhner, S | 1 |
| Ferrero, S; Leone Roberti Maggiore, U; Remorgida, V; Scala, C; Tafi, E; Venturini, PL | 1 |
| Cook, RM; Kaplan, D; Rondina, MT; Vo, TL | 1 |
| Jensen, JT; Nguyen, BT | 1 |
| Matarasso, A; Myers, RS; Paresi, RJ | 1 |
| Agarwal, N; Bhatla, N; Gupta, M; Kriplani, A; Singh, N | 1 |
| Feldman, R; Fox, MC; Frenkl, TL; Wang, Y; Yacik, C | 1 |
| Chang, Q; Di, W; Fan, GS; Korver, T; Marintcheva-Petrova, M; McCrary Sisk, C; Qin, Y; Ren, M; Su, P; Wang, G; Wu, S; Yacik, C | 1 |
| Desai, M; Evans-Strickfaden, T; Haaland, RE; Holder, A; Huey, MJ; Humwa, F; Makanga, M; McLellan-Lemal, E; Nyagol, B; Oyaro, B; Williams, T | 1 |
| Battaglia, B; Battaglia, C; Casadio, P; Guasina, F; Mattioli, M; Morotti, E | 1 |
| Beretta, M; Eder, S; Eggenreich, K; Friedrich, M; Froehlich, E; Khinast, JG; Koscher, G; Koutsamanis, I; Nickisch, K; Paudel, A; Roblegg, E; Witschnigg, A | 1 |
| Abbott, K; Alexander, J; Breiter, H; Gallagher, V; Herrold, A; Kramer, N; Lindley, T; Mjaanes, J; Reilly, J | 1 |
| Agaba, S; Buyze, J; Crucitti, T; De Baetselier, I; Delvaux, T; Jespers, V; Kestelyn, E; Mwambarangwe, L; Ndagijimana, JC; Umulisa, MM; Uwineza, M; van de Wijgert, JHHM; Van Nuil, JI | 1 |
| Cruz, SM; Duijkers, I; Fayad, GN; Frenkl, TL; Heger-Mahn, D; Klipping, C; Korver, T | 1 |
| Del Savio, MC; Facchinetti, F; Grandi, G; Sammarini, M; Timò, A | 1 |
| Beath, S; Parkin, CJ; Rasiah, K | 1 |
6 review(s) available for ethinyl estradiol and nuvaring
| Article | Year |
|---|---|
Review of the vaginal contraceptive ring (NuvaRing).
Topics: Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Patient Satisfaction | 2008 |
The contraceptive vaginal ring.
Topics: Contraceptive Agents, Female; Contraceptive Devices, Female; Delayed-Action Preparations; Desogestrel; Drug Combinations; Drug Interactions; Estrogens; Ethinyl Estradiol; Female; Humans; Progestins; Self Administration | 2010 |
The vaginal ring (NuvaRing®) for contraception in adolescent women.
Topics: Adolescent; Contraception; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Pregnancy; Pregnancy in Adolescence; Sexual Behavior; Young Adult | 2012 |
The contraceptive vaginal ring, NuvaRing(®), a decade after its introduction.
Topics: Administration, Intravaginal; Contraception Behavior; Contraceptive Agents; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Patient Acceptance of Health Care; Transdermal Patch; Treatment Outcome | 2012 |
Transurethral placement of vaginal contraceptive device in a patient with neurogenic bladder: a case report and review of the literature.
Topics: Contraceptive Devices, Female; Desogestrel; Device Removal; Drug Combinations; Ethinyl Estradiol; Female; Foreign-Body Migration; Humans; Radiography; Ultrasonography; Urethra; Urinary Bladder, Neurogenic; Vagina; Young Adult | 2013 |
Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring.
Topics: Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Female; Humans; Polyvinyls; Risk | 2014 |
19 trial(s) available for ethinyl estradiol and nuvaring
| Article | Year |
|---|---|
Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone.
Topics: Administration, Oral; Adult; Androstenes; Body Composition; Body Weight; Contraceptive Devices, Female; Contraceptives, Oral; Desogestrel; Drug Combinations; Ethinyl Estradiol; Humans; Intrauterine Devices; Menstrual Cycle; Patient Compliance | 2006 |
Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
Topics: Adolescent; Adult; Androstenes; Contraception; Contraceptive Agents; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Patient Compliance; Patient Satisfaction; Pregnancy; Progesterone Congeners; Treatment Outcome | 2006 |
Clinical experience with NuvaRing in daily practice in Switzerland: cycle control and acceptability among women of all reproductive ages.
Topics: Adolescent; Adult; Age Factors; Blood Pressure; Body Weight; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Patient Acceptance of Health Care; Pregnancy; Prospective Studies; Surveys and Questionnaires; Switzerland | 2007 |
Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids.
Topics: Administration, Intravaginal; Adult; Anti-Mullerian Hormone; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Pancuronium | 2008 |
Use of the NuvaRing hormone-releasing system in late reproductive-age women with type 1 diabetes mellitus.
Topics: Adult; Aging; Blood Glucose; Carbohydrate Metabolism; Contraceptive Devices, Female; Desogestrel; Diabetes Mellitus, Type 1; Drug Combinations; Ethinyl Estradiol; Female; Glycated Hemoglobin; Hemostasis; Humans; Lipid Metabolism | 2008 |
An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRing.
Topics: Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Metrorrhagia; Middle Aged; Patient Compliance | 2008 |
Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Metrorrhagia; Progestins | 2008 |
Sexual function in first-time contraceptive ring and contraceptive patch users.
Topics: Administration, Cutaneous; Administration, Intravaginal; Adult; Contraception; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Linear Models; Male; Patient Satisfaction; Prospective Studies; Sexual Behavior; Sexual Dysfunction, Physiological; Sexual Partners; Surveys and Questionnaires; Time Factors; United States; Young Adult | 2010 |
Adherence and acceptability of the contraceptive ring compared with the pill among students: a randomized controlled trial.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Medication Adherence; Patient Satisfaction; Students; Universities; Young Adult | 2010 |
Effect on carbohydrate metabolism and analysis of acceptability (menstrual cycle control) of extended regimens of the vaginally inserted hormone-releasing system 'NuvaRing' as compared with the standard 21/7 regime in reproductive-age women with type 1 di
Topics: Administration, Intravaginal; Adult; Blood Glucose; Carbohydrate Metabolism; Contraceptive Agents, Female; Desogestrel; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Glycated Hemoglobin; Humans; Insulin; Intrauterine Devices, Medicated; Menstrual Cycle; Patient Acceptance of Health Care | 2010 |
Combined contraceptive ring versus combined oral contraceptive (30-μg ethinylestradiol and 3-mg drospirenone).
Topics: Acne Vulgaris; Adolescent; Adult; Affective Symptoms; Androstenes; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Leukorrhea; Libido; Lipoproteins, LDL; Metrorrhagia; Vaginitis; Weight Gain; Young Adult | 2011 |
A randomized controlled trial of NuvaRing versus combined oral contraceptive pills for pretreatment in in vitro fertilization cycles.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Fertilization in Vitro; Humans; Infertility, Female; Ovarian Cysts; Ovary; Patient Satisfaction; Pregnancy; Pregnancy Rate; Young Adult | 2011 |
Contraceptive vaginal ring treatment of heavy menstrual bleeding: a randomized controlled trial with norethisterone.
Topics: Adult; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menorrhagia; Norethindrone; Patient Satisfaction; Prospective Studies; Quality of Life; Young Adult | 2012 |
Desogestrel-only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open-label comparative study.
Topics: Adult; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Endometriosis; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Patient Satisfaction; Prospective Studies; Rectal Diseases | 2014 |
Comparison of combined hormonal vaginal ring with ultralow-dose combined oral contraceptive pills in the management of heavy menstrual bleeding: A pilot study.
Topics: Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menorrhagia; Pilot Projects | 2016 |
Safety and efficacy of the NuvaRing® Applicator in healthy females: a multicenter, open-label, randomized, 2-period crossover study.
Topics: Adolescent; Adult; Contraceptive Devices, Female; Cross-Over Studies; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Fingers; Humans; Middle Aged; Surveys and Questionnaires; Vagina; Young Adult | 2016 |
Efficacy and safety of the contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive in Chinese women: a 1-year randomised trial.
Topics: Adolescent; Adult; China; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Medication Adherence; Metrorrhagia; Young Adult | 2016 |
A randomised trial of a contraceptive vaginal ring in women at risk of HIV infection in Rwanda: Safety of intermittent and continuous use.
Topics: Adult; Contraception; Contraceptive Agents; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; HIV Infections; Humans; Pregnancy; Rwanda; Vagina | 2018 |
Phase II dose-finding study on ovulation inhibition and cycle control associated with the use of contraceptive vaginal rings containing 17β-estradiol and the progestagens etonogestrel or nomegestrol acetate compared to NuvaRing.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Estradiol; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Outcome Assessment, Health Care; Ovulation Inhibition | 2018 |
21 other study(ies) available for ethinyl estradiol and nuvaring
| Article | Year |
|---|---|
Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
Topics: Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Randomized Controlled Trials as Topic; Research Design | 2007 |
Clinical inquiries. What hormonal contraception is most effective for obese women?
Topics: Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Evidence-Based Medicine; Female; Humans; Medroxyprogesterone Acetate; Norgestrel; Obesity; Pregnancy; Pregnancy Rate; Risk Assessment | 2007 |
Vaginal yeast adherence to the combined contraceptive vaginal ring (CCVR).
Topics: Biofilms; Candida; Candidiasis, Vulvovaginal; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Saccharomyces cerevisiae | 2007 |
[Nuvaring is a novel contraception method].
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans | 2007 |
Interference in urinary free cortisol determination by components of the NuvaRing contraceptive device.
Topics: Adult; Artifacts; Cross Reactions; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Immunoassay; Pregnancy; Urine | 2008 |
[NuvaRing-combined contraceptive vaginal ring: state of art in 2008. Expert Board of Polish Gynecological Society].
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Gynecology; Health Knowledge, Attitudes, Practice; Humans; Intrauterine Devices, Medicated; Natural Family Planning Methods; Obstetrics; Patient Education as Topic; Poland; Pregnancy; Pregnancy, Unplanned; Women's Health | 2008 |
The vaginal ring: expelled or misplaced?
Topics: Adult; Desogestrel; Device Removal; Drug Combinations; Ethinyl Estradiol; Female; Foreign-Body Reaction; Humans; Prosthesis Implantation; Ultrasonography; Urinary Tract Infections | 2009 |
[The vaginal contraceptive ring].
Topics: Aftercare; Contraceptive Devices, Female; Contraindications; Desogestrel; Drug Combinations; Equipment Failure; Ethinyl Estradiol; Female; Humans; Patient Education as Topic; Patient Selection; Risk Factors; Sex Education | 2009 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
[Vaginal combined contraception NuvaRing in the clinical practice in the Czech Republic].
Topics: Adult; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Patient Satisfaction; Young Adult | 2009 |
Suspect online sellers and contraceptive access.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral; Counterfeit Drugs; Desogestrel; Drug Combinations; Drug Implants; Ethinyl Estradiol; Female; Humans; Injections; Intrauterine Devices; Medroxyprogesterone Acetate; Pharmaceutical Services, Online; Safety | 2012 |
Investigating the feasibility of temperature-controlled accelerated drug release testing for an intravaginal ring.
Topics: Administration, Intravaginal; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Delayed-Action Preparations; Desogestrel; Diffusion; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Female; Humans; Kinetics; Permeability; Polymers; Quality Control; Solubility; Temperature; Vagina | 2013 |
Cardiovascular risk associated with the use of an etonogestrel-containing vaginal ring.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Product Surveillance, Postmarketing; Prospective Studies; Risk Assessment; Venous Thromboembolism; Young Adult | 2013 |
Cerebral venous sinus thrombosis in the setting of combined vaginal contraception.
Topics: Adult; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Risk Factors; Sinus Thrombosis, Intracranial; Venous Thromboembolism | 2014 |
Contraceptive Vaginal Rings: Do They Pose an Increased Risk of Venous Thromboembolism in Aesthetic Surgery?
Topics: Abdominoplasty; Administration, Intravaginal; Adult; Anticoagulants; Breast Implantation; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Embolectomy; Ethinyl Estradiol; Female; Humans; Pulmonary Embolism; Risk Assessment; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis | 2015 |
Residual hormone levels in used contraceptive rings as a measurement of adherence to vaginal ring use.
Topics: Administration, Intravaginal; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Kenya; Patient Compliance; United States | 2017 |
Weight gain, body image and sexual function in young patients treated with contraceptive vaginal ring. A prospective pilot study.
Topics: Adolescent; Adult; Body Dysmorphic Disorders; Body Mass Index; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Health Knowledge, Attitudes, Practice; Humans; Italy; Overweight; Pilot Projects; Prospective Studies; Psychiatric Status Rating Scales; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Weight Gain; Young Adult | 2017 |
Establishment of a Molding Procedure to Facilitate Formulation Development for Co-extrudates.
Topics: Chemistry, Pharmaceutical; Delayed-Action Preparations; Desogestrel; Drug Combinations; Drug Compounding; Drug Liberation; Ethinyl Estradiol; Vacuum | 2017 |
The Effects of Sex Differences and Hormonal Contraception on Outcomes after Collegiate Sports-Related Concussion.
Topics: Athletic Injuries; Brain Concussion; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Male; Recovery of Function; Sex Characteristics; Students; Universities; Young Adult | 2018 |
Surface roughness of different contraceptive vaginal rings: evaluation by scanning electron microscope (SEM).
Topics: Biomass; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Microscopy, Electron, Scanning; Polyvinyls; Surface Properties; Vagina | 2020 |
A NuvaRing caught in the wrong spot.
Topics: Desogestrel; Drug Combinations; Ethinyl Estradiol; Humans | 2022 |